Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A multi-centre, double-blind, placebo-controlled, randomised trial of combination methotrexate and gefitinib versus methotrexate alone to treat tubal ectopic pregnancies (GEM3): trial protocol.
May J, Duncan C, Mol B, Bhattacharya S, Daniels J, Middleton L, Hewitt C, Coomarasamy A, Jurkovic D, Bourne T, Bottomley C, Peace-Gadsby A, Doust A, Tong S, Horne AW. May J, et al. Among authors: doust a. Trials. 2018 Nov 20;19(1):643. doi: 10.1186/s13063-018-3008-6. Trials. 2018. PMID: 30458863 Free PMC article.
Phase II single arm open label multicentre clinical trial to evaluate the efficacy and side effects of a combination of gefitinib and methotrexate to treat tubal ectopic pregnancies (GEM II): study protocol.
Horne AW, Skubisz MM, Doust A, Duncan WC, Wallace E, Critchley HO, Johns TG, Norman JE, Bhattacharya S, Mollison J, Rassmusen M, Tong S. Horne AW, et al. Among authors: doust a. BMJ Open. 2013 Jul 19;3(7):e002902. doi: 10.1136/bmjopen-2013-002902. Print 2013. BMJ Open. 2013. PMID: 23872290 Free PMC article.
Gefitinib and Methotrexate to Treat Ectopic Pregnancies with a Pre-Treatment Serum hCG 1000-10,000 IU/L: Phase II Open Label, Single Arm Multi-Centre Trial.
Skubisz MM, Tong S, Doust A, Mollison J, Johns TG, Neil P, Robinson M, Bhattacharya S, Wallace E, Krzys N, Colin Duncan W, Horne AW. Skubisz MM, et al. Among authors: doust a. EBioMedicine. 2018 Jul;33:276-281. doi: 10.1016/j.ebiom.2018.06.017. Epub 2018 Jun 22. EBioMedicine. 2018. PMID: 29941341 Free PMC article. Clinical Trial.
A two-arm parallel double-blind randomised controlled pilot trial of the efficacy of Omega-3 polyunsaturated fatty acids for the treatment of women with endometriosis-associated pain (PurFECT1).
Abokhrais IM, Denison FC, Whitaker LHR, Saunders PTK, Doust A, Williams LJ, Horne AW. Abokhrais IM, et al. Among authors: doust a. PLoS One. 2020 Jan 17;15(1):e0227695. doi: 10.1371/journal.pone.0227695. eCollection 2020. PLoS One. 2020. PMID: 31951599 Free PMC article. Clinical Trial.
Correction: A two-arm parallel double-blind randomised controlled pilot trial of the efficacy of Omega-3 polyunsaturated fatty acids for the treatment of women with endometriosis-associated pain (PurFECT1).
Abokhrais IM, Denison FC, Whitaker LHR, Saunders PTK, Doust A, Williams LJ, Horne AW. Abokhrais IM, et al. Among authors: doust a. PLoS One. 2020 Feb 27;15(2):e0230055. doi: 10.1371/journal.pone.0230055. eCollection 2020. PLoS One. 2020. PMID: 32106274 Free PMC article.
Laparoscopic treatment of isolated superficial peritoneal endometriosis for managing chronic pelvic pain in women: study protocol for a randomised controlled feasibility trial (ESPriT1).
Whitaker LHR, Doust A, Stephen J, Norrie J, Cooper K, Daniels J, Hummelshoj L, Cox E, Beatty L, Chien P, Madhra M, Vincent K, Horne AW. Whitaker LHR, et al. Among authors: doust a. Pilot Feasibility Stud. 2021 Jan 7;7(1):19. doi: 10.1186/s40814-020-00740-9. Pilot Feasibility Stud. 2021. PMID: 33413677 Free PMC article.
66 results